Medical Weight Loss for Delray Beach, Florida Residents
Delray Beach, Florida residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Delray Beach through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Delray Beach Residents Choose New Hope Weight Loss
Delray Beach patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Florida and beyond since 2020.
From our Costa Mesa, California practice, we provide Delray Beach with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.
In Delray Beach, Florida, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout downtown Delray Beach, Atlantic Avenue, and southern Palm Beach County. Every prescription for Delray Beach is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
Whether you live in central Delray Beach or its outskirts, you get exactly the same care and the same price. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you before you begin.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Delray Beach
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Delray Beach
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Delray Beach address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Delray Beach
Does New Hope Weight Loss treat patients in Delray Beach?
Yes. Although the clinic is in Costa Mesa, California, we treat Delray Beach, Florida residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Delray Beach?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Delray Beach address in cold-pack packaging.
What do Delray Beach patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Delray Beach do you serve?
We serve patients from across Delray Beach by telehealth, including downtown Delray Beach, Atlantic Avenue, and southern Palm Beach County.
What support is there for side effects for Delray Beach patients?
Dr. Sharma starts Delray Beach patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Delray Beach, Florida by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.